International Conference on Antimicrobial Resistance, Novel Drug Discovery, and Vaccine Development: Challenges and Opportunities – Vision 2030
Introduction
The fight against infectious diseases has entered a critical phase, with antimicrobial resistance (AMR) emerging as a major global health crisis. To address this pressing issue, the International Conference on Antimicrobial Resistance, Novel Drug Discovery, and Vaccine Development: Challenges and Opportunities – Vision 2030 aims to bring together leading researchers, healthcare professionals, and policymakers. This event will provide a platform to discuss the challenges and advancements in tackling drug-resistant pathogens and the future of drug discovery and vaccine development.
About the Conference
The conference will focus on various aspects of AMR, including:
- Multi-extensive drug-resistant pathogens
- Hospital-acquired infections
- Host-pathogen interactions
- Infection and immunity
- Microbial pathogenesis
- Antimicrobial stewardship
- Challenges and opportunities in drug discovery
- Vaccine development against infectious diseases
Special attention will be given to diseases such as Tuberculosis (TB), Malaria, Kala-Azar, Dengue, and COVID-19. The conference will also foster scientific networking and future collaborations to combat AMR effectively.
About SGT University
Shree Guru Gobind Singh Tricentenary (SGT) University, Gurugram, was established under the Haryana Private Universities (Amendment) Act No. 8, 2013. It was founded by the Dashmesh Educational Charitable Trust and has grown into a premier educational institution offering around 160+ courses across 18 faculties.
Spread over 70 acres of lush greenery, SGT University provides an ideal environment for professional education and research. Inspired by the teachings of Shree Guru Gobind Singh Ji, the university remains committed to spreading knowledge and fostering holistic student development.
About the R&D Cell
The Research & Development (R&D) Cell at SGT University plays a pivotal role in nurturing research culture across various disciplines. With a strong emphasis on interdisciplinary and international collaborations, the R&D Cell aims to:
- Expand research opportunities for undergraduate and postgraduate students
- Foster ethical research practices in line with global standards
- Revise policies to align with emerging research trends
- Promote innovation and entrepreneurship for societal well-being
About the University of Southampton
The University of Southampton is a globally recognized research-intensive institution and a founding member of the Russell Group. With seven campuses specializing in Humanities, Oceanography, Medicine, Engineering, and Art, it offers a diverse range of academic disciplines.
In 2024, it became the first UK university to establish a campus in India, strengthening its commitment to international education and research. With over 22,000 students, Southampton is dedicated to addressing global challenges through interdisciplinary collaboration and innovation.
About IHFC (Technology Innovation Hub, IIT Delhi)
The IHFC (I-Hub Foundation for Cobotics) at IIT Delhi was established under the Department of Science and Technology (DST), Government of India, as part of the National Mission on Interdisciplinary Cyber-Physical Systems (NM-ICPS). The initiative focuses on:
- Research and development in cyber-physical systems
- Incubating and promoting startups in healthcare technology
- Collaboration with medical professionals, engineers, and entrepreneurs
- Establishing the Medical Cobotics Centre (MCC), a center of excellence for training and skill development in medical robotics and healthcare devices
Conclusion
The International Conference on AMR, Novel Drug Discovery, and Vaccine Development will be a groundbreaking event, bringing together global experts to discuss cutting-edge research and solutions to combat drug-resistant infections. By fostering collaboration among leading universities, research institutions, and industry professionals, this conference will shape the future of antimicrobial stewardship, innovative drug discovery, and vaccine development.
Stay tuned for updates and join us in this global fight against AMR!
Introduction
The fight against infectious diseases has entered a critical phase, with antimicrobial resistance (AMR) emerging as a major global health crisis. To address this pressing issue, the International Conference on Antimicrobial Resistance, Novel Drug Discovery, and Vaccine Development: Challenges and Opportunities – Vision 2030 aims to bring together leading researchers, healthcare professionals, and policymakers. This event will provide a platform to discuss the challenges and advancements in tackling drug-resistant pathogens and the future of drug discovery and vaccine development.
About the Conference
The conference will focus on various aspects of AMR, including:
- Multi-extensive drug-resistant pathogens
- Hospital-acquired infections
- Host-pathogen interactions
- Infection and immunity
- Microbial pathogenesis
- Antimicrobial stewardship
- Challenges and opportunities in drug discovery
- Vaccine development against infectious diseases
Special attention will be given to diseases such as Tuberculosis (TB), Malaria, Kala-Azar, Dengue, and COVID-19. The conference will also foster scientific networking and future collaborations to combat AMR effectively.
About SGT University
Shree Guru Gobind Singh Tricentenary (SGT) University, Gurugram, was established under the Haryana Private Universities (Amendment) Act No. 8, 2013. It was founded by the Dashmesh Educational Charitable Trust and has grown into a premier educational institution offering around 160+ courses across 18 faculties.
Spread over 70 acres of lush greenery, SGT University provides an ideal environment for professional education and research. Inspired by the teachings of Shree Guru Gobind Singh Ji, the university remains committed to spreading knowledge and fostering holistic student development.
About the R&D Cell
The Research & Development (R&D) Cell at SGT University plays a pivotal role in nurturing research culture across various disciplines. With a strong emphasis on interdisciplinary and international collaborations, the R&D Cell aims to:
- Expand research opportunities for undergraduate and postgraduate students
- Foster ethical research practices in line with global standards
- Revise policies to align with emerging research trends
- Promote innovation and entrepreneurship for societal well-being
About the University of Southampton
The University of Southampton is a globally recognized research-intensive institution and a founding member of the Russell Group. With seven campuses specializing in Humanities, Oceanography, Medicine, Engineering, and Art, it offers a diverse range of academic disciplines.
In 2024, it became the first UK university to establish a campus in India, strengthening its commitment to international education and research. With over 22,000 students, Southampton is dedicated to addressing global challenges through interdisciplinary collaboration and innovation.
About IHFC (Technology Innovation Hub, IIT Delhi)
The IHFC (I-Hub Foundation for Cobotics) at IIT Delhi was established under the Department of Science and Technology (DST), Government of India, as part of the National Mission on Interdisciplinary Cyber-Physical Systems (NM-ICPS). The initiative focuses on:
- Research and development in cyber-physical systems
- Incubating and promoting startups in healthcare technology
- Collaboration with medical professionals, engineers, and entrepreneurs
- Establishing the Medical Cobotics Centre (MCC), a center of excellence for training and skill development in medical robotics and healthcare devices
Conclusion
The International Conference on AMR, Novel Drug Discovery, and Vaccine Development will be a groundbreaking event, bringing together global experts to discuss cutting-edge research and solutions to combat drug-resistant infections. By fostering collaboration among leading universities, research institutions, and industry professionals, this conference will shape the future of antimicrobial stewardship, innovative drug discovery, and vaccine development.
Stay tuned for updates and join us in this global fight against AMR!